1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 6th Edition

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 6th Edition

  • April 2014
  • -
  • Kalorama Information
  • -
  • 200 pages

Summary

Table of Contents

Search Inside

For six editions, this authoritative resource has defined the market opportunity for companies assisting in the beginning phase of the drug development process.

This Kalorama Information Report, Outsourcing in Drug Discovery, t provides an in depth look into the trends that have shaped the drug discovery outsourcing market today, and details the current and future global market. As part of its coverage, the report provides markets and forecasts for the following segments.

Chemistry Services Market: Building Blocks, Compound
Synthesis, Libraries, Process Research, and Other Services,
Biology Market Revenue by Protein Expression, Structural
Analysis, Target Validation, Pathways Analysis, and Other Service
Screening Services Market: Assay Development, Primary
Screening, Secondary Screening
Lead Optimization Services Market: Early ADMET/Tox, Create Analogues, Computational Support, and Other Services

The drug discovery process consists of iterative cycles between chemistry and biology that begin with the target finding phase, or selecting a protein (a drug target) leading to the identification of a chemical compound with biological activity (a hit). After confirmation of biological activity and chemical feasibility, the hit becomes a lead structure, which is improved through chemical modifications until it fulfills the criteria for a clinical candidate. A drug candidate then moves into the next stage of drug development, the preclinical phase.

The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a target protein or nucleic acid in a way that is useful for treatment of disease. The process by which molecules are identified for their therapeutic value involves synthesis and analysis of many derivatives of the original leads. There are several steps in the drug discovery process including hit confirmation, lead generation, lead optimization, and other studies. Drug discovery is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will actually yield products that achieve regulatory approval by the Food & Drug Administration (FDA).Since the last edition of Kalorama's Report on the outsourcing of discovery, major trends that have led to an increase in demand for contract services in drug discovery include:The following companies are profiled in the report:

Albany Molecular Research, Inc.
Aptuit, LLC
Argenta Discovery, Ltd.
Asclepia MedChem Solutions
Asinex Ltd.
AsisChem, Inc.
Axxam SpA
BioDuro
BioFocus DPI
Caliper Life Sciences
Charles River Laboratories, Inc.
ChemBridge Corp.
Chemical Diversity Inc.
Covance, Inc.
CreaGen Biosciences, Inc.
Crown Bioscience
Cyprotex PLC
Domainex
Emerald Biostructures
Enamine Ltd.
Evotec AG
Exelgen Discovery
GVK Biosciences Private Limited
GenScript USA Inc.
Graffinity Pharmaceuticals GmbH
Hutchison MediPharma Ltd.
Jubilant Biosys Ltd
Nanosyn, Inc.
Pharmaron Inc.
Ricerca Biosciences, LLC
Scynexis, Inc.
Selcia Limited
Selvita S.A.
Shanghai ChemPartner Co., Ltd.
Shanghai Medicilon Inc.
Sundia Meditech Company, Ltd.
Sygnature Discovery Limited
TCG Lifesciences Limited
Viva Biotech, Ltd
WuXI AppTec Co. Ltd.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Clinical Trial Supply and Logistics Market for Pharma 2017-2027

Global Clinical Trial Supply and Logistics Market for Pharma 2017-2027

  • $ 3135
  • Industry report
  • February 2017
  • by Visiongain

Report Details The Global Clinical Trial Supply and Logistics Market is expected to grow at a CAGR of 7.0% from 2016-2021 and CAGR of 5.6% from 2021-2027. The market is expected to grow at a CAGR of 6.2% ...

Global High-Throughput Screening Market - Growth, Trends and Forecasts (2017 - 2022)

Global High-Throughput Screening Market - Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The global high-throughput screening (HTS) market is estimated to be USD 16.75 billion in 2016 and is projected to reach USD 22.68 billion by 2021, growing at a CAGR of 6.25% during the forecast period. ...

Global Clinical Trial Support Services Market - Growth, Trends and Forecasts (2017 - 2022)

Global Clinical Trial Support Services Market - Growth, Trends and Forecasts (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The Global Clinical Trial Support Services Market is estimated to be $ xx billion for the year 2015 to reach $ xx billion by the year 2020. The CAGR with which market is growing is anticipated to be x.x%. ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.